期刊文献+

神经纤维瘤病Ⅱ型一家系临床特点及基因突变分析 被引量:2

Clinical features and gene mutation analysis of a family of neurofibromatosis type 2
原文传递
导出
摘要 神经纤维瘤病Ⅱ型(neurofibromatosis type 2,NF2)是一种比较罕见的常染色体显性遗传疾病,其特征性表现为双侧前庭神经鞘瘤,另外还常常伴有皮下神经纤维瘤、晶状体后囊浑浊、脑膜瘤、室管膜瘤、胶质瘤、脊髓肿瘤等[1]。NF2致病基因位于染色体22q12.2,NF2基因突变导致其编码的merlin蛋白功能异常或缺乏从而引起肿瘤生长[2]。笔者现报道NF2一家系患者的临床特征、实验室检查、影像学特征、治疗及预后、基因突变特点等资料,以提高临床工作者对该病的认识。
作者 史晓曼 李桐 崔君昭 田晶 李培芳 段士茹 刘亚玲 孙轶杰 刘晓云 Shi Xiaoman;Li Tong;Cui Junzhao;Tian Jing;Li Peifang;Duan Shiru;Liu Yaling;Sun Yijie;Liu Xiaoyun(Department of Neurology,Second Hospital of Hebei Medical University,Shijiazhuang 050000,China;Second Outpatient Department,Affiliated Hospital of Hebei University,Shijiazhuang 050051,China)
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2022年第7期710-714,共5页 Chinese Journal of Neuromedicine
  • 相关文献

参考文献3

二级参考文献42

  • 1Nevison B, Laszig R, Sollmann WP, et al. Results from a European clinical investigation of the Nucleus multichannel auditory brainstem implant. Ear Hear, 2002, 23(3):170-183.
  • 2. Samii M, Matthies C, Tatagiba M. Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2. Neurosurgery, 1997,40(4) : 696-706.
  • 3Brackmann DE, Fayad JN, Slatttery WH, et al. Early proactive management of vestibular schwannomas in neurofibromatosis type 2. Neurosurgery, 2001,49(2) : 274-283.
  • 4Rowe JG, Radatz MW, Walton L, et al. Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis. J Neurol Neurosurg Psychiatry, 2003, 74(9) : 1288- 1293.
  • 5Subach BR, Kondziolka D, Lunsford LD, et al. Stereotactic radiosurgery in the management of acoustic neuromas associated with neurofibromatosis type 2. J Neurosurg, 1999, 90( 5): 815-822.
  • 6Evans DG, Sainio M, Baser ME. Neurofibromatosis type 2. J Med Genet, 2000, 37(12) : 897-904.
  • 7Evans DGR, Huson SM, Donnai D, et al. A genetic study of type 2?neurofibromatosis in the United Kingdom.Ⅰ. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet, 1992, 29(12) : 841-846.
  • 8Kluwe L, Mautner V, Heinrich B, et al. Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas. J Med Genet, 2003,40(2) : 109-114.
  • 9Baser ME, Friedman JM, Wallace AJ, et al. Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology, 2002, 59 ( 11 ) :1759-1765.
  • 10Moffat DA, Quaranta N, Baguley DM, et al. Management strategies in neurofibromatosis type 2. Eur Arch Otorhinolaryngol, 2003, 260 ( 1 ):12-18.

共引文献9

同被引文献23

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部